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Bacteriophage therapy is currently resurging as a potential complement/alternative to antibiotic 
treatment. However, preclinical evaluation lacks streamlined approaches. We here focus on preclinical 
approaches which have been implemented to assess bacteriophage efficacy against Pseudomonas 
biofilms and infections. Laser interferometry and profilometry were applied to measure biofilm 
matrix permeability and surface geometry changes, respectively. These biophysical approaches were 
combined with an advanced Airway Surface Liquid infection model, which mimics in vitro the normal 
and CF lung environments, and an in vivo Galleria larvae model. These assays have been implemented 
to analyze KTN4 (279,593 bp dsDNA genome), a type-IV pili dependent, giant phage resembling phiKZ. 
Upon contact, KTN4 immediately disrupts the P. aeruginosa PAO1 biofilm and reduces pyocyanin 
and siderophore production. The gentamicin exclusion assay on NuLi-1 and CuFi-1 cell lines revealed 
the decrease of extracellular bacterial load between 4 and 7 logs and successfully prevents wild-type 
Pseudomonas internalization into CF epithelial cells. These properties and the significant rescue 
of Galleria larvae indicate that giant KTN4 phage is a suitable candidate for in vivo phage therapy 
evaluation for lung infection applications.
Pseudomonas aeruginosa is a metabolically versatile Gram-negative bacterium that can cause a wide range of 
opportunistic hospital-acquired infections. Individuals with open wounds, cancer, compromised immune sys-
tems and chronic pulmonary conditions, such as cystic fibrosis (CF) are particularly susceptible1–3. P. aeruginosa 
can undergo phenotypic and genotypic changes in response to the environmental signals during infection and 
lives as planktonic cells, colonies or biofilms4. The increasing frequency of multidrug-resistant strains is par-
ticularly concerning as treatment options are severely limited in the absence of effective antibiotics5,6. There is a 
general need to establish novel strategies for the development of new antibacterial treatments or effective prophy-
lactics as well as new diagnostic tools to identify CF pathogen virulence determinants. One of the possibilities is 
bacteriophages, the natural parasites of bacteria. Phage cocktails have been applied as alternative or as supportive 
treatments simultaneously with antibiotics for P. aeruginosa eradication causing various infection such as puru-
lent wounds, septicemia, urinary tract or lung infections7–9. A number of studies have presented phages with a 
potent bactericidal effect against CF isolates, reducing the lung bacterial burden in in vitro and in vivo models10–14. 
The capacity of phages to eradicate bacterial biofilms is an important aspect towards their successful implemen-
tation in in vivo treatments. To gain access to the bacterial cell, phages have developed specific strategies to over-
come the biofilm. A major evolutionary development in this regard is the production of highly specific enzymes 
like polysaccharide depolymerases or alginate lyases. These enzymes allow the phages to invade the bacterial cells 
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entrapped in the polysaccharide backbone by degradation of biofilm structure. Moreover, the bacteria released 
from exopolysaccharide matrix, become accessible for antimicrobials or host immune system components15–19. 
The phiKZ-like phages and their gene products may play an important role in control of pathogenic pseudomon-
ads20,21. Some of these phages have already been incorporated into traditional phage therapy cocktails and con-
tinue to be examined for novel therapeutic applications22–24. Phikzvirus constitute a genus of ‘jumbo’ myoviruses, 
lytic against a variety of Pseudomonas species25,26. To date, over twenty phiKZ-related phages have been found 
in diverse geographic locations from soil, water, or have been recently characterized from historical therapeutic 
phage preparations26. PhiKZ-related phages have a large icosahedral head (~122 nm in diameter) and a long 
(~190 nm) contractile tail surrounded by fibers. Inside the capsid a large cylindrical “inner body” (15–20 MDa, 
consisting of at least six different proteins), holds the genomic DNA27,28. This long conserved head component 
spanning the whole giant capsid wall-to-wall was observed in phiKZ-related phages, e.g. 201 ϕ 2–1, ϕ PA3, EL, 
OBP26. Their genomes are very large (between 211 and 317 kb of non-redundant sequence) and compose of circu-
larly permuted, terminally redundant linear double-stranded and A+T-rich (> 52%) DNAs29.
This work describes the genome organization and biology of a novel phiKZ isolate KTN4, and its antibacterial 
potential is examined using novel biofilm assays (interferometry and profilometry) as well as a novel Airway 
Surface Liquid model on nonCF and CF epithelial cells lines, in an effort to mimic in vivo conditions of the res-
piratory tract as closely as possible. Indeed, the ASL covering the lung surface consists of a mucus and a periciliary 
liquid layer. The former traps and removes inhaled pathogens, while the latter keeps the mucus at an optimal 
distance from the underlying epithelia to maximize ciliary mobility, provides a low viscosity solution and acts as 
a lubricant layer for mucus transport. Together, they play a critical role in effective mucociliary clearance of the 
airway30,31. Due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) in CF airways, 
ion channel abnormalities are observed and the innate and adaptive immune responses are impaired. Moreover, 
the decreased ASL volume or altered mucus impede phagocyte function, making bacterial elimination defective, 
inflammatory response abnormal, and mucociliary clearance reduced. CF airways have a sticky mucus provid-
ing the perfect milieu, microaerophilic to anaerobic environment, enabling the colonization and propagation of 
P. aeruginosa32.
Results and Discussion
Isolation and morphology. Lytic phage KTN4 was isolated from sewage samples collected from irrigated 
fields located in Wroclaw, Poland. After purification phage titres were 1010–1011 pfu/ml and caused ~1.7 mm 
wide clear plaques with halo zone on 0.6% soft agar. The KTN4 morphology was examined by transmission elec-
tron microscopy (TEM) and classified to the Phikzlikevirus, order Caudovirales, family Myoviridae (Figure S1)25. 
The isolate was formally named vB_PaeM_KTN4 (KTN4). The isometric head size can be estimated at 130 nm 
between opposite apices, the tail and base plate is 168 nm long.
Molecular analysis and taxonomic context. Genome sequence analysis revealed KTN4 as a giant phage 
of 279,593 bp, highly similar (> 99% genome-wide DNA homology, conserved regulatory elements and genome 
organisation) to Pseudomonas phage phiKZ. A detailed genome and proteome analysis is provided within a 
dedicated supplementary section, showing minor differences to phiKZ (Suppl. 1, Table S1, Figures S2–S4). An 
experimental structural proteome analysis (ESI-MS/MS) allowed the identification of 111 virion-associated gene 
products (out of 368 predicted open reading frames in total). To place this phage into its broader taxonomic 
context, a protein sharing network, comprising 495 Caudovirales and unclassified phages with 6,948 relationships 
(edges) between them, was generated (Fig. 1). As expected, phage KTN4 was placed in a single component with 
five well-known Pseudomonas phiKZ-related phages including phiKZ, phiPA3, 201phi2-1, EL and OBP33, as well 
as four other phages phiJM-2012, SPN3US, CR5, and phiEaH2, which was separated from other components.
One-step growth and stability tests. One-step growth experiments indicated a latent period of 40 min 
and a burst size of about 6–8 phage particles per infected bacterial cell. The stability test revealed that KTN4 is 
relatively stable in a broad range of temperature and pH. No reduction of pfu/ml was observed over a period of 
60 min at a temperature of 40–70 °C, while 1 hour incubation at 80 °C and 15 min incubation at 90 °C decreased 
the titer with 4 and 6 log, respectively. After 1 hour incubation at room temperature at pH between 6 and 12 over 
90% phages remained infective. At a pH of 3–4 around 10% of particles showed the lytic activity, while pH 2 
reduced the titer to less than 1%. No significant change in KTN4 titer was observed after 50% chloroform treat-
ment for 1 h incubation at room temperature and at 4 °C.
Determination of phage receptor and host range. In the study based on PAO1 mutants it was 
observed that KTN4 requires the presence of IV type pili on the surface of the host cell as its receptor (Table 1). 
The lytic activity of KTN4 was examined on two independent P. aeruginosa panels. In the previous paper, 43 clini-
cal P. aeruginosa strains from COST international reference panel were used14. The KTN4 phage was able to infect 
32.6% isolates, compared to representatives of the N4-like group (LUZ7 41.9%), the phiKMV-like group (LUZ19 
44.2%), the PB1-like group (LBL3 39.5%, KT28 27.9%, KTN6 41.9%), the phiKZ-like group (phiKZ 46.5%) and 
a novel jumbo phage PA5oct 23.9%. In presented study, phage KTN4 exhibited a broad spectrum of activity 
against 58 clinical strains from Military Hospital Neder-Over-Heembeek, Brussels, Belgium34. KTN4 was able to 
infect 46.6% strains, whereas representatives of the N4-like group (LUZ7 34.5%, LIT1 12.1%), LUZ24-like group 
(LUZ24 22.4%), phiKMV-like group (LUZ19 39.7%, LKD16 31.0%, LKA1 3.5%, KMV 32.7%), and PB1-like 
group (LBL3 46.6%, LMA2 24.1%, LSL4 17.2%, KT28 58.6%, KTN6 67.2%) mostly show a narrower spectrum 
(Table S2).
An interesting observation here is the differences in host range between KTN4 and phiKZ, despite the strong 
homology between both phages. Indeed, tail sheath, tube, fiber, tip (gp39/181/40//182/166) and baseplate 
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associated proteins (gp131-135) are all > 98% identical to phiKZ. However, it was previously shown that only 
minor point mutations can result in host range differences35. A noticeable difference within the genome is asso-
ciated to the presence of predicted HNH-endonucleases. It could be theoretically possible that their presence in 
DNA metabolism/structural protein coding genes could impact host range.
Phage influence on biofilm characteristics covering Nephrophane membrane. The anti-biofilm 
activity of giant phage KTN4 was evaluated by spectrophotometry and a fluorescence assay, and compared with 
the efficacy of colistin, an anti-pseudomonal drug (Fig. 2). The activity of colistin was first adjusted on 24 h PAO1 
biofilm growing in microtiter plates and the biofilm mass was evaluated by CV staining. Based on the above 
results, a concentration of 100 μ M colistin was selected (Fig. 2A). Afterwards, experiments were performed on 
the PAO1 biofilm grown on a Nephrophane membrane for three time periods (24, 48 and 72 h). In the Fig. 2B, 
the CV staining of biofilm biomass eradication showed significant effect of active KTN4 and colistin combined 
with active phage against 72 h-old biofilm. The colistin alone significantly reduced the biomass of the biofilm 
formed for 24 h. In contrast, the CV assay showed an increase of biomass after intact phage particles treatment 
of 24 h biofilm. No biofilm mass eradication was noticed for inactivated phages regardless of biofilm age and the 
combination with colistin. In general, the CV staining did not reveal efficient eradication results both for phage 
and antibiotic. We suspect that phage propagation on the cells embedded in early biofilm leads to the release of 
exopolysaccharide degrading enzymes (of phage or bacterial origin), in turn resulting in a relative increase of 
negatively charged moieties in biofilm matrix. These moieties are detected during crystal violet staining as bio-
film biomass increase. As discussed recently17, we have concluded that this phenomenon is a limitation of the CV 
assay. As a consequence, other methods have been applied to evaluate phage potency to affect biofilm forming 
bacteria. For this purpose, the analysis of pyocyanin and pyoverdin/pyochelin secretion to the medium by spec-
trophotometry and fluorometry was used, allowing detection of highly diffusible pigmented signaling molecules 
levels of quorum sensing and a siderophore36–39.
The analysis of pyocyanin concentration in growth medium showed that active phages, colistin and active 
phage/colistin treatment significantly decreased the level of this compound for the tested biofilms (24, 48 or 
72 h) compared to UV-inactivated phages (Fig. 2C). It turned out that infective form of giant phage significantly 
reduced the concentration of pyocyanin, whether combined with colistin or alone. The level of pyoverdin deter-
mined by the fluorescence was significantly lowered after colistin application on 24 h biofilm and in combination 
with both phage preparations on PAO1 biofilm formed for 72 h (Fig. 2D). The reduction of siderophore concen-
tration was also observed when 72 h biofilms were exposed to active KTN4. The combined treatment consisting of 
phage and antibiotic did not show a synergistic effect in either biomass or dyes determination assays. This obser-
vation is consistent with previous observations for two Pseudomonas PB1-like phages17. Moreover, the positive 
correlation between bacterial cells growth, biofilm formation, pyocyanin and siderophore levels in supernatants 
Figure 1. Protein-sharing network for KTN4. (A) A network representation was produced using the edge-
weighted spring embedded layout of Cytoscape version 3.1.1. Nodes indicate phage genomes and edges between 
two nodes indicate their statistically weighted pairwise similarities with phage-phage similarity scores of ≥ 1.  
There are 495 nodes and 6,948 edges in this network. (B) An enlarged view of the circle in Panel B. Values 
are the similarity scores estimated with the hypergeometric equation shown in Materials and methods. Edge 
thickness is proportional to protein sequence identity, which is represented in the legend box.
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has been found, indicating that the reduced levels of Pseudomonas-specific compounds are related to the phage’s 
activity. Statistically significant (p < 0.005) inhibition observed for pyocyanin and pyoverdin/pyochelin produc-
tion was elicited by phages (lysis of cells in biofilm). The quantities of the most important pigmented signal-
ing molecules secreted by the pathogen decreased significantly, which proves the potency of these phages to be 
applied in Pseudomonas biofilm treatment.
The phage application effect on biofilm disruption was analyzed by laser interferometry17,40, a biophysical 
technique which measures quantitative changes in biofilm matrix permeability for low molecular compounds 
(Fig. 3). This experiment was not performed for colistin, since no activity of the drug for three-days biofilm could 
be measured. The diffusion of TSB medium though biofilm was evaluated, which indirectly indicated its structure 
degradation. The hydrophilic Nephrophane membrane overgrown by 72 h biofilm was chosen for the interferom-
etry analysis. At this moment, the PAO1 biofilm fully covers the Nephrophane membrane, necessary as a scaffold 
used in the laser interferometry method (Fig. 3). In addition, this 72 h time point allows comparison to other 
approaches (Fig. 2). ASM medium containing the components of cystic fibrosis patient sputum, including amino 
acids, mucin and free DNA was also attempted for biofilm culturing, as well. Unfortunately, the level of membrane 
coverage by PAO1 biofilm formed in ASM medium was too low (18–26%) and biophysical investigation by inter-
ferometry analysis proved problematic.
The PAO1 biofilm was treated with active and UV-inactivated KNT4 phage for 4 h. The diffusion rate of medium 
transported though the biofilm-covered membrane (0.86 × 10−3 mg/h) was significantly higher than for intact 
biofilm (p < 0.001) after active and inactivated phage treatment, reaching 1.65 × 10−3 mg/h and 1.39 × 10−3 mg/h, 
respectively. The increase of diffusion rate through the overgrown membrane after phage application indicated the 
degradation of the biofilm structure associated with the disintegration of matrix elements. It should be empha-
sized that the increase of the diffusion was also obtained after the application of inactivated particles, suggesting 
that tested phages may display an exopolysaccharide depolymerase, responsible for phage particle spread within 
the biofilm matrix. However, this could not be supported experimentally.
The effect of KTN4 phage treatment on biofilm disruption was also analyzed by ZETA-20 non-contact optical 
profiler, a novel 3D measurement technique. Two of the system imaging modes (Z-DotTM and Nomarski (ZIC)) 
were used to determine the 3D profile of tested surface with the reflection on natural colors (Fig. 4). The yellow 
color of PAO1 biofilm (Fig. 4B) formed on the grey Nephrophane membrane was associated with the production 
of siderophores by bacterial cells within a mature biofilm. After the incubation with KTN4 phage, the color of 
degraded biofilm was similar to native membrane. It indicated that phage was able to inhibit the production of 
siderophore by PAO1 cells. Moreover, several parameters of surface roughness was also measured what allowed 
to analyze the physical changes in the biofilm geometry. The surface structure, described by Rsk parameter, 
has changed after incubation with phage preparation. The biofilm surface was smoother after phage treatment 
observed as the skewness parameter (Rsk) decreased from 0.40 ± 0.28 before treatment to 0.14 ± 0.39 post phage 
treatment (p = 0.108).
Considering the phage/colistin eradication efficacy of PAO1 biofilm, a rapid action of colistin compared to 
phages was observed. This could be associated with differences of diffusion kinetics between both tested anti-
bacterial agents. The laser interferometry analysis of colistin diffusion (from initial concentration 1.2 mg/ml) 
through PAO1 biofilm formed for 72 h at 37 °C showed that only 12.17 μ g/ml (about 1%) of colistin was trans-
ported after 40 min (data not shown). This indicates that the concentration of colistin in the old PAO1 biofilm was 
at a sub-inhibitory level. In contrast, the concentration of antibiotic likely reaches a bactericidal level in the early 
Bacterial strain Phenotype Origin KTN4 ϕKZ
PAO1 (ATCC 15692) Wild type American Type Culture Collection + + 
PAO1 Pirnay Wild type with inactive type IV pili Military Hospital Nederoverheembeek, Brussels, Belgium, Dr. Jean-Paul Pirnay − −
PAO1 Krylov Wild type Military Hospital Nederoverheembeek, Brussels, Belgium, Dr. Jean-Paul Pirnay + + 
PAO1 Δ rmd (A−, B+ ) Deficiency in D-rhamnose biosynthesis; lack of A-band LPS
Laboratory of Foodborne Zoonoses, Guelph, 
Canada, Andrew M. Kropinski + + 
PAO1 Δ rmLC (A−, B−, core-) Deficiency in L-rhamnose biosynthesis; truncate core region, lack of A-band and B-band LPS
Laboratory of Foodborne Zoonoses, Guelph, 
Canada, Andrew M. Kropinski + + 
PAO1 Δ waaL (A−, B−)
Lack of WaaL ligating O-polymer to core-lipid A; 
LPS is devoid of A-band and B-band, semirough 
(SR-LPS, or core-plus-one O-antigen)
Laboratory of Foodborne Zoonoses, Guelph, 
Canada, Andrew M. Kropinski + + 
PAO1 Δ wbpL (A−, B−) Lack of glucosyltransferase WbpL essential for initiation of both A-band and B-band synthesis
Laboratory of Foodborne Zoonoses, Guelph, 
Canada, Andrew M. Kropinski + + 
PAO1 Δ fliC Δ algC Δ pilA
Lack of flagella; lack of AlgC required for A-band, 
core oligosaccharide, and alginate biosynthesis; lack 
of type IV pili
Technical University Hamburg, Germany, 
Max Schöbert − −
PAO1 Δ fliC wt algC Δ pilA Lack of flagella; lack of type IV pili Technical University Hamburg, Germany, Max Schöbert − −
PAO1 Δ fliC wt algC wt pilA Lack of flagella Technical University Hamburg, Germany, Max Schöbert + + 
PAO1 wt fliC wt algC wt pilA Wild type Technical University Hamburg, Germany, Max Schöbert + + 
Table 1.  Phage receptor identification on P. aeruginosa PAO1 mutants.
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biofilm. The possible answer for the lack of synergy between phage and antibiotic can be explained by the mode 
of action and receptor targeted by each antibacterial agent. Colistin causes the cell death by destabilizing cell 
membrane, which limits phage propagation. In addition, KTN4 phage recognises IV-type pili and therefore nei-
ther increases nor inhibits colistin activity. In Fig. 2, both antibacterials work independently and the bactericidal 
activity was cumulated, yet not greater than the effect of each individual compound. Considering anti-biofilm 
assays in general, it seems that when comparing the CV assay to the novel approaches such as laser interferometry 
and profilometry (ZETA-20, Zeta Instruments Co., San Jose, USA), the latter turned out to be more efficient and 
precise techniques, providing important insights on the degradation and permeability feature of biofilm matrix, 
and surface geometry changes including several roughness (R) parameters and diffusible pigmented signaling 
molecules production by biofilm forming bacteria.
Antibacterial efficacy of KTN4 phage analyzed in gentamicin exclusion assay on Airway Surface 
Liquid infection model. In our study, in vitro antibacterial activity of KTN4 phage was assessed in gen-
tamicin exclusion assay on ASL, which is to our knowledge, the first report showing phage treatment efficacy 
in that infection model. For experiments, two cell lines were selected: 1) NuLi-1 derived from normal human 
Figure 2. The antibacterial effect of colistin against 24 h PAO1 biofilm formed on Nephrophane membrane (A);  
the anti-biofilm effect of KTN4 phage/colistin treatment on 24, 48 and 72 h PAO1 biofilm formed on Nephrophane 
membrane: the biomass evaluation by CV staining (B); the level of pyocyanin in growth medium (C); 
the fluorescence of pyoverdin in growth medium (D). Untreated biofilm was used as control. The results are 
presented as the means ± SD. Statistical analysis was made by the ANOVA test (denoted p-values < 0.05).
Figure 3. Laser interferometry analysis of TSB medium diffusion through PAO1 biofilm treated with 
phages. Untreated biofilm was used as control. The results are presented as the means ± SD from three 
independent experiments.
www.nature.com/scientificreports/
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Figure 4. The 3D surface optical profile analysis of Nephrophane membrane, PAO1 biofilm and PAO1 
biofilm after KTN4 phage bacteriophage degradation measured by ZET 20 instrument (A). The Nephrophane 
roughness (R) parameters measured by ZET 20 (B). The results are presented as the means ± SD. Statistical 
analysis was made using an ANOVA test (denoted p-values < 0.05).
www.nature.com/scientificreports/
7Scientific RepoRts | 6:28115 | DOI: 10.1038/srep28115
bronchial epithelium and 2) CuFi-1 derived from CF patient bronchial epithelium with significantly thinner 
ASL31. Three P. aeruginosa strains were selected for these experiments: PAO1 reference strain (piliated, motile 
strain, effective biofilm former), a nonCF0038 isolate from burn wound (highly expressing type IV pili), both 
reflecting CF early colonizing isolates, which are non-mucoid with typically smooth LPS and more virulent. 
The third strain was CF708 from late infection phase, presenting slowly growing and less virulent small colony 
variants (SCVs) with low expression of type IV pili, and biofilm formation18. First, both epithelial cell lines were 
infected with selected strains for 3 h and colony count showed P. aeruginosa efficiently propagated in both ASLs 
(107–109 cfu/ml) (Fig. 5). Although PAO1 and nonCF0038 pathogens grew better on NuLi-1 cell line, reaching 
around 1 log higher compared to CuFi-1 ASL, no statistics significance has been found (p > 0.05). The small 
colony variant CF708 grew equally well in both types of mucus layer. In the second step of experiment, the 
KTN4 phage eradication ability of the extracellular bacterial load was evaluated. CFU counts of P. aeruginosa 
were significantly (p < 0.05) reduced for the normal NuLi-1 epithelia cells. A 7 log, 6 log and 4 log decrease was 
observed for PAO1, nonCF0038 and CF708, respectively (Fig. 5A). In the case of the CuFi-1 epithelia the phage 
treatment was also very effective giving 4 log, 6 log and 5 log reductions in colony count of PAO1, nonCF0038 and 
CF708 (p < 0.05), respectively (Fig. 5A). PAO1 was significantly more susceptible (p < 0.05) to phage treatment in 
NuLi-1 cells compared to CuFi-1 cells, contrary to the CF708 isolate. It was confirmed that the KTN4 phage could 
freely diffuse and gain access to the bacterial hosts in both ASL models, but the final result of the treatment was 
strongly dependent on the strain features or due to different ASL pH between NuLi-1 and CuFi-1 cells. A possible 
explanation of this phenomenon was observed by Worlitzsch’s studies32 where P. aeruginosa was not interacting 
with the CF epithelium directly, but was rather found trapped in mucus plugs formed in the airways. Thus, the 
phage receptors could be masked by mucus elements, which have an influence on phage adsorption to bacterial 
cell surface. Moreover, the CF strain is better adapted to CuFi-1 environment and may presumably express the 
type IV pili more efficiently, which are receptors for KTN4 phage.
In the next step of our experiment, the ability of P. aeruginosa strains to invade into epithelial cells was inves-
tigated (Fig. 5B). Although P. aeruginosa was generally thought to be an extracellular pathogen, a number of dif-
ferent groups have found that it can be internalized into a range of different cell types, including epithelial cells3,41. 
The results showed that CF and non-CF strains could indeed internalize into both cell lines with no statistically 
significant differences (p > 0.05) were observed for all pathogens. Nonetheless, the PAO1 and nonCF0038 were 
much less ingested by epithelium compared to the CF708 isolate, where only 4.50E-05% and 2.00E-04–5.00E-05% 
of infecting population were able to internalize into NuLi-1 and CuFi-1 cells, respectively, in contrast to 0.05% and 0.06% 
for CF708 isolate. Clearly the internalization capability and adaptations of CF708 strain were more effective com-
pared to the nonCF strains, consistent with previous observations41. This suggests that the Pseudomonas strains 
Figure 5. Phage KTN4 treatment of P. aeruginosa infected NuLi-1 and CuFi-1 epithelial cells. (A) Colony 
count of bacteria collected from apical wash; (B) colony count of bacteria internalized in epithelial cells. 
The results are presented as the means ± SD. Statistical analysis was made by the ANOVA test (denoted p-
values < 0.05).
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with high cytotoxicity are low invasive and vice versa, bacteria less virulent enter the epithelial cells to survive 
intracellularly without killing the host cell.
In the final step, the influence of KTN4 phage treatment on the number of invaded bacteria was evaluated 
(Fig. 5B). In the NuLi-1 cell line there were no significant changes (p > 0.05) in CFU counts for all P. aeruginosa 
invading strains after phage application. A possible explanation is that during the 3 hours of pretreatment, all bac-
terial cells were already internalized, thus the phage had no access to these host cells. In contrast, the phage appli-
cation was significantly more effective (p < 0.05) for CuFi-1 internalization prevention by wild type P. aeruginosa 
strains, since CF lung cells due to lack of CFTR, show significantly less ingestion rate of LPS-smooth bacteria and 
significantly greater lung burdens post-infection than wild-type epithelium3. As previously mentioned32, wild 
strains not well adopted to the ‘sticky’ and dense CF environment are absent on epithelial surface but remain 
as macrocolonies within intraluminal material, slowing down efficient internalization. Simultaneously, phage 
application cause effective eradication of bacterial cells trapped in the mucus plugs. The CF708 isolate evolving in 
CF patient is able to internalize with the CuFi-1 epithelium in relatively short time after infection evading phage 
lytic activity.
Antibacterial efficacy of KTN4 phage analyzed in vivo on wax moth larvae model. The wax 
moth larvae model has been chosen for the in vivo assay because the P. aeruginosa, as a natural Galleria pathogen, 
is highly virulent in these insects when inoculated directly into the hemolymph42,43. The lethal dose causing fast 
infection progress was established as follows: 10 CFU for PAO1 and nonCF0038 strains and 106 CFU of CF708 
isolate per larvae and the treatment was carried out by the injection of phage lysate at multiplicity of infection 
(MOI) of 100 (Fig. 6). The negative controls (uninfected and receiving phage lysate larvae (N = 30 per condition) 
gave a 100% survival rate. The 10 CFU of PAO1 and nonCF0038 strains caused 100% caterpillar mortality (N = 30 
per condition) after one day of infection. The small colony variant CF708 isolate even at very high inoculum (106 
CFU) was significantly less virulent than former ones (p < 0.0001) with the delay of killing 35% and 50% after 
three and four/five days of infection (N = 60), respectively.
The KTN4 phage application showed a significant impact on Galleria larval survival rate from lethal PAO1 
infection, with 90% of alive caterpillars 36 h post injection (p < 0.0001). The protective activity of the phage 
against nonCF0038 propagation was much less efficient, saving only 20% of larvae at the same time (p < 0.0001). 
The antibacterial activity of applied phage against CF708 isolate was seen at the very end of the experiment 
(fourth/fifth day) with 68% survival rate of treated larvae (p > 0.05) in comparison to 50% of untreated control.
The results obtained in G. mellonella model generally correlate with data observed for NuLi-1 cells in 
ASL infection assay, where the bacterial count of PAO1 was reduced by KTN4 phage more efficiently than of 
nonCF0038 strain, although the later was described as a strong type IV pili former (the principal KTN4 recep-
tor). The possible explanation of this effect could be the biochemical clonally variation of non-CF308 population 
examined by Fourier transform infrared spectroscopy (FTIR) analysis in the spectra window of carbohydrates 
and lipids, in our previous study18. This may influence the stronger variation of phage susceptible cells among 
treated non-CF308 population. Comparing presented Galleria experiment to our previous study performed on 
the same strains18, the protective efficacy (p < 0.0001) of KTN4 phage was similar to the activity of another giant 
phage PA5oct tested in Olszak et al. study, which rescued 90% of caterpillars after two days of PAO1 infection. The 
increased larval survival rate in the presence of PB1-like phage (100% at the same time) compared to the giants 
ones, could suggest the importance of phage size and phage generation time rate (KT28 < PA5oct and KTN4) in 
the therapeutic results18.
In the moth larvae model, an antibacterial potential of KTN4 phage was shown against P. aeruginosa. There 
are some arguments that the administration of bacteriolytic agent (antibiotic, phage) in the treatment of infec-
tion, especially caused by Gram-negative bacteria, may result in severe consequences as Systemic Inflammatory 
Response Syndrome due to the rapid release of lipopolysaccharide (LPS) during lysis of a big number of cells in 
a short period of time. Nonetheless, the acute infection phage therapy data, as well as for bactericidal antibiotics, 
have shown that removing the pathogen population has profound effect on reducing proinflammatory cytokines 
leading to successful treatment.
Conclusions
Genome and proteome analysis, as well as a protein-sharing network indicates that KTN4 phage belongs to 
“jumbo” Myoviridae and it is closely related to phiKZ phage. This lytic virus has a broad spectrum of activity with 
prevalence to clinical isolates, especially from CF patients. Moreover, this phage has a very strong bactericidal 
effect (4–7 log reduction of colony count) against P. aeruginosa strains, as tested in a ASL model. To our knowl-
edge this is the first study of phage application using this lung epithelia infection assay. The gentamicin exclusion 
assay on ASL in vitro model is flexible, generates reproducible data with well-controlled and standardized con-
ditions, mimicing the normal and CF lung environments. Moreover, it provides a basis for understanding the 
host-pathogen interactions and is, as such, an important step towards experimental in vivo studies. Indeed, the 
Galleria larvae model provides a first confirmation of the in vivo potential of the antibacterial efficacy of KTN4 
phage against clinical isolates, albeit in a strain dependent manner.
Since Pseudomonas common infections are usually associated with biofilm formation, the ability of KTN4 to 
disrupt the biofilm has been examined in detail. The phage demonstrated a strong anti-biofilm potential immedi-
ately after application. In contrast to the commonly used CV assay, novel biophysical techniques (interferometry 
and profilometry) have proven to be sensitive and reproducible techniques, providing information on changes in 
biofilm permeability and the 3D structure, during the biofilm structure degradation process.
Considering all these characteristics, KTN4 phage is a suitable and promising candidate for in vivo trials, for 
applications in treatment and prophylaxis in lung infections.
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Methods
Isolation, propagation and purification of phages. The Pseudomonas aeruginosa PAO1 (ATCC 15692) 
strain was used as phage propagation host. Environmental water samples from irrigated fields in Wroclaw, Poland 
were centrifuged (15,000 g for 15 min) and the supernatant was filtered through a 0.22 μ m Millex-GP filter (Merck 
Millipore, Germany) to remove bacterial debris. Pseudomonas phage KTN4 has been propagated as previously 
described17. Phage lysate was purified with CsCl-gradient ultracentrifugation as described by Ceyssens et al.44. 
The phage titre of the solution was assessed using the double-agar layer technique45. The virion morphology in 
transmission electron microscopy (TEM) was established according to the method described elsewhere17.
DNA isolation and sequencing. Phage DNA was isolated according to the modified protocol for λ DNA 
isolation46 after CsCl gradient purification of phage particles (1010 pfu/ml). Whole genome sequencing was per-
formed by use of the Illumina MiSeq platform available at the Nucleomics Core (VIB, Belgium). A 2* 150 bp 
paired-end library (Nextera XT sample prep) was prepared and sequenced. The reads were assembled in a single 
contig with a 100–6000 fold coverage using CLC genomics Workbench de novo assembly algorithm (CLC bio, 
Qiagen Company). The genome of bacteriophage KTN4 was deposited at GenBank under accession number 
KU521356.
In silico genome analysis. Potential ORFs were identified using the GeneMark S47, GeneMark.hmm48, 
OrfFinder49 and manually analyzed. Translated ORFs were compared to known proteins using BLASTP50, the 
HHpred server51 and HMMER52, providing further insight into the predicted function of proteins. Conserved 
protein domains were identified using the Pfam53, InterPro54 and PHYRE255. Putative tRNA genes were searched 
for using the tRNAscan-SE program56. The intergenic regions were screened for regulatory elements using 
fuzznuc57 and manually evaluated. Putative factor-independent terminators were identified with ARNOLD 
software58.
Protein family clustering and network construction and analyses. To represent the genetic rela-
tionships of KTN4 with other phages as a gene (protein)-sharing network, each predicted protein was clus-
tered into protein families using the ACLAME database (version 0.4)59 with the database of “viruses” and an 
Figure 6. Antibacterial activity of KTN4 phage (MOI 100) in the treatment of infected Galleria larvae 
by PA strains. Positive control consisted of infected but untreated larvae and KTN4 control was larvae group 
receiving phage lysate only. Statistical analysis was calculated for pair wise comparisons between infected larvae 
and phage treated infected larvae using Mantel-Cox test (denoted p-values < 0.05).
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E-value < 0.00160. Additionally, for the phages that share significant gene contents with KTN4 but are absent in 
the ACLAME database, 2,592 protein sequences were retrieved from phiKZ (NC_004629), phiPA3 (HQ630627), 
201phi2-1 (NC_010821), EL (NC_007623), OBP (NC_016571), phiJM-2012 (JQ340088), SPN3US (NC_027402), 
CR5 (NC_021531), and phiEaH2 (NC_019929). The proteins that could not be assigned into any ACLAME pro-
tein families were defined as the unclassified protein families (UPFs) as previously described61. We accepted 
the transitive nature of sequence families62, i.e., a sequence is added to a cluster if it shares a reciprocal best hit 
relationship with at least one of the sequences of the cluster. The degree of similarity between other phages was 
generated as the minus logarithmic score by multiplying hypergeometric similarity P-value by the total number 
of pairwise comparisons60. Afterwards, a protein-sharing network was built with the Cytoscape software platform 
(version 3.1.1; http://cytoscape.org/), using an edge-weighted spring embedded model. Topological properties of 
the network were estimated with the Network Analyzer 2.7 Cytoscape plug-in63.
ESI-MS/MS analysis of structure-associated proteins. Phage proteins were extracted from a purified 
phage suspension (1011 pfu/ml) by a single methanol/chloroform extraction (1:1:0.75, v/v/v) (Acros Organics) 
and subsequently precipitated by addition of an equal volume of methanol (16,060 g, 6 min). The dried phage 
protein pellet was resuspended in SDS-PAGE loading buffer and boiled for 5 min before loading onto a 12% 
SDS-PAGE gel. Protein gels were stained afterwards with GelCode Blue Safe (Thermo Scientific). Further, the 
entire lane of a phage protein profile was prepared for ESI- MS/MS as previously described64,65.
Burst size experiments and Sensitivity of phage particles to heat, chloroform and pH. A 
one-step growth curve was performed according to the method of Pajunen et al.66 with modifications. An equal 
volume of bacterial culture (at optical density at 600 nm of 0.4) was mixed with phage suspension (106 pfu/ml) to 
obtain a multiplicity of infection of 0.01. Phages were allowed to adsorb for 8 min at 37 °C, after which the mixture 
was diluted to 10−4. Triplicate samples were taken during 1 h at 5 min intervals and titrated. The sensitivity of 
phage particles to heat, chloroform and pH were performed according to previously described methods17.
Phage typing and phage receptor analysis. The lytic activity of KTN4 was examined on 58 clinical 
strains from Military Hospital Neder-Over-Heembeek, Brussels, Belgium collection34 for comparison to other 
Pseudomonas phages including: N4-like group (LUZ7, LIT1), LUZ24-like group (LUZ24), phiKMV-like group 
(LUZ19, LKD16, LKA1, KMV), PB1-like group (LBL3, LMA2, LSL4, KT28, KTN6) (Table S3). Moreover, the 
phage specificity to particular bacterial receptor was tested on PAO1 mutants deficient in biosynthesis of A-band 
and B-band O-antigen, flagella, IV type pili, or alginate production (Table 1). For all phage experiments 4–6 h 
old bacterial cultures were used, unless otherwise stated. To determine bacterial susceptibility to phage-mediated 
lysis, a drop of the phage suspension (108 pfu/ml) was put on a bacterial lawn and incubated at 37 °C. The plates 
were checked after 4–6 h and again after 18 h for the presence of a lysis zone67.
Phage influence on biofilm characteristics covering Nephrophane membrane. Nephrophane 
(VEB Filmfabrik, Wolfen, Germany) is a microporous, highly hydrophilic membrane made from cellulose ace-
tate ([trio-acetate cel-(OCO-CH3)n]) of a spongy structure40,68. The analysis of biofilm degradation by intact 
and UV-inactivated phages was performed by microbiological methods as well as biophysical techniques. In 
the first step of the study, the antibacterial effect of colistin against PAO1 biofilm formed in TSB medium for 
24 h at 37 °C was determined. This step was made in microtitre plates using the CV (0.004% crystal violet) assay. 
Afterwards, the Nephrophane membrane was covered by a PAO1 biofilm formed for either 24, 48 or 72 h at 37 °C 
in TSB medium. Next, the biofilm was treated for 4 hours with KTN4 phage (5 × 108 pfu/ml) and/or colistin at 
a 100 μ M concentration at 37 °C. After incubation, the biofilm was stained with CV (0.004%) for 15 min or was 
tested for pyocyanin and pyoverdin/pyochelin levels in the supernatants, as previously described17. Pyoverdin and 
pyochelin are the two major siderophores produced by Pseudomonas aeruginosa in iron-limited media. The lex 
for pyoverdine is between 380–400 nm (depending on pH) and lem is 447 nm, lex for pyochelin is 313 nm and lem 
is 430 nm69. We decided to use lex = 398 nm and lem = 460 nm as more specific for pyoverdin in our experiment, 
but we cannot exclude (partial) detection of the pyochelin portion in the detected signal of siderophores due to 
spectral overlap. The degradation of biofilm by phages is associated with increase of the permeability of its matrix 
for low molecular compounds. The quantitative measurements of cultivation medium (TSB) diffusion through 
biofilm structure after incubation with phages might indicate on disruption of its structure. This degrading activ-
ity of KTN4 phage on PAO1 biofilm was tested by laser interferometry method as presented elsewhere17,40. The 
level of Nephrophane membrane covered by biofilm was determined as 92.4%. The interferometry system con-
sisted of two glass cuvettes, separated by the horizontally located Nephrophane membrane, covered with PAO1 
biofilm formed for 72 h at 37 °C. The KTN4 phage treatment (5 × 108 pfu/ml) was carried out for 4 h at 37 °C. All 
experiments were performed in triplicate.
PAO1 biofilm surface geometry, its physical parameters as well as true color of 3D optical profile were deter-
mined by ZETA-20 (Zeta Instruments Co., San Jose, USA). Two imaging modes, Z-DotTM Optical Profiler and 
Nomarski (ZIC), were applied. Measurements were made for 188 μ m × 141 μ m areas with a resolution 0.046 μ m 
in the Z axis. Several roughness (R) parameters were defined: Ra – arithmetical mean deviation, Rq – root mean 
square deviation, Rp – maximum profile peak height, Rv – maximum profile valley depth, Rsk – skewness, 
Rz – maximum height of profile, and Rku – kurtosis of profile. For each of these parameters the value minimum, 
maximum, mean, standard deviation and relative error has been determined.
Gentamicin exclusion assay on Airway Surface Liquid infection model. NuLi-1 (Normal Lung, 
University of Iowa), derived from human airway epithelium of normal genotype, and a CF cell line, called CuFi-1 
(Cystic Fibrosis, University of Iowa), derived from bronchial epithelium of a homozygous CFTR F508del/F508del 
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individual, were kindly provided by Zabner (University of Iowa, Iowa City, IA). The ASL model was prepared 
according to methods described elsewhere by Zabner31. Both cell lines were inoculated with 25 μ l of P. aeruginosa 
PAO1 reference strain (6.2 × 107 cfu/ml), nonCF0038 isolate from burn wound (6.5 × 107 cfu/ml) and CF708 
small colony variant (1.0 × 106 cfu/ml) at optical density at 600 nm of 0.1, and incubated for 1.5 h at 37 °C, 5% 
CO2. The 25 μ l of KTN4 phage suspension (8.5 × 1010 pfu/ml) was added to each millicell hanging cell culture 
insert. Subsequently, cells were incubated for 1.5 h at 37 °C, 5% CO2. Next, cells were washed with PBS and apical 
washes were serially diluted in DMEM:F12 medium (Sigma-Aldrich) and quantified by viable counts on LB 
agar (Sigma-Aldrich) after 24 hours. To evaluate the ability of P. aeruginosa to invade into epithelial cells and 
the ability of phage KTN4 to prevent this invasion, extracellular and adherent bacteria were killed by addition 
of 400 μ g/ml gentamicin (Thermo-Fisher Scientific) and incubated for 1 h at 37 °C, 5% CO2. The drug was subse-
quently removed by PBS washing and epithelial cells were lysed with 0.4% Triton-X100 (Sigma-Aldrich) 100 μ l 
for 15 min at 37 °C, 5% CO2. The resulting lysate was serially diluted in DMEM:F12 medium and quantified by 
viable counts on LB agar after 24 hours. The gentamicin MICs for tested strains were as follows: 0.5 μ g/ml, 2 μ g/ml, 
and 64 μ g/ml, for PAO1, nonCF0038 and CF708, respectively. Several controls of epithelial cells viability were 
prepared: (i) a negative control without any treatment, (ii) a negative control with TC media; (iii) a positive con-
trol with Triton-X100; (iv) 1.5 h after KTN4 treatment; (v) 1,5 h after strains treatment. The Nuli-1 and CuFi-1 
cells were stained with 8 μ M Calcien AM (live staining) (Life Technologies, NY, USA) and 3 μ M propidium iodide 
(PI) (dead staining) (Life Technologies, NY, USA) according to manufacturer’s instructions. Negative controls 
(untreated) and positive controls (0.25% Triton-X100 treated) were included in the experimental set up. After 
staining, in all cases, filter inserts were XZ scanned using a confocal microscope (Zeiss LSM 510 Meta 40× objec-
tive, Jena, Germany). No toxicity influence of cell lines was noticed for phage and bacteria samples.
Statistical analysis. The data were analyzed using the Statistica software package (StatSoft, Tulsa, OK, 
USA). All the values were expressed as mean ± SD and significant differences between variations (denoted 
p-values < 0.05) were found by means of the Snedecor-Fisher test using one-way ANOVA.
Galleria mellonella larvae model. The in vivo assay was conducted on a wax moth larvae model according 
to the methodology described previously18. Briefly, larvae were inoculated with 10 μ l lethal dose of bacterial cells 
established as follows: 10 CFU of PAO1 and nonCF0038 strains and 106 CFU of CF708 isolate per larvae. After 
injection into the ventral side of the last pair of pseudopods, the larvae were incubated for 96/120 hours at 37 °C. 
For assessment of the antibacterial activity of KTN4 phage, larvae were sequentially injected with 10 μ l of bacte-
rial suspension and 10 μ l of phage lysate at the titration equal to multiplicity of infection (MOI) 100. The results 
were read at 18, 24, 36, 48, 72 and 96/120 hours post injection and were expressed as the percentage survival rate 
assessed by macroscopic appearance. Experiments were performed in triplicate (10 larvae per trial). The controls 
consisted of uninfected and larvae receiving phage lysate only (negative) and infected with bacterial lethal dose 
(positive). The analysis of survival curves was performer by log-rank Mantel-Cox test. P-values < 0.05 were con-
sidered statistically significant. Statistical analysis was performed using GraphPad Prism software (GraphPad 
Software, Inc., La Jolla, USA).
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